J
Jerónimo Saiz-Ruiz
Researcher at University of Alcalá
Publications - 181
Citations - 6777
Jerónimo Saiz-Ruiz is an academic researcher from University of Alcalá. The author has contributed to research in topics: Poison control & Suicide attempt. The author has an hindex of 44, co-authored 173 publications receiving 6249 citations. Previous affiliations of Jerónimo Saiz-Ruiz include Complutense University of Madrid & Columbia University.
Papers
More filters
Journal Article
Ziprasidona: de la farmacología a la práctica clínica. Un año de experiencia
TL;DR: Results from different clinical trials show that the use of doses in the higher range is associated to a faster and more pronounced clinical improvement without adding a higher risk of adverse events.
Journal ArticleDOI
Personality traits and acetylator status
Jerónimo Saiz-Ruiz,J.C. Aguilera +1 more
TL;DR: Gyldensted C (1977): Measurements of normal ventricular system and hemispheric sulci of 100 adults with computed tomography.
Journal Article
Acute tryptophan depletion in eating disorders
Marina Díaz-Marsá,C Lozano,A. S Herranz,M. J Asensio-Vegas,O Martín,L Revert,Jerónimo Saiz-Ruiz,José L. Carrasco +7 more
TL;DR: The tryptophan depletion test could be of value to study involvement of serotonin deficits in the symptomatology and pathophysiology of eating disorders.
Journal ArticleDOI
Cyp2d6 polymorphism and mental and personality disorders in suicide attempters
Hilario Blasco-Fontecilla,Eva M Peñas-Lledó,Concepción Vaquero-Lorenzo,Pedro Dorado,Jerónimo Saiz-Ruiz,Adrián LLerena,Enrique Baca-García +6 more
TL;DR: In this paper, the association between CYP2D6 polymorphism and mental and personality disorders among suicide attempters was explored. But the main objective of the study was not to explore whether mental disorders mediate this association.
Journal ArticleDOI
Patient characteristics driving clinical utility in psychiatric pharmacogenetics: a reanalysis from the AB-GEN multicentric trial.
José M. Menchón,Jordi Espadaler,Miquel Tuson,Jerónimo Saiz-Ruiz,Julio Bobes,Eduard Vieta,Enric Álvarez,Enric Álvarez,Virgili Pérez +8 more
TL;DR: Reanalysis of data from the AB-GEN randomized clinical trial shows that clinical utility of pharmacogenetic testing can be markedly influenced by patient characteristics such as age, baseline severity and duration of current depressive episode.